In both models, the risks of PCP diagnosis were similar whether or not a patient was receiving PCP prophylaxis (adjusted IRR 0.95, p = 0.901 among all patients; adjusted IRR 1.39, p = 0.560 among patients with CD4 counts of less than 200 cells/mm3). Here, CD4 is linked to pneumocystosis.